MITRAL VALVE DISEASE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Takeaways from Analyst

Global mitral valve disease market can witness growth significantly over the forecast period due to rising prevalence of rheumatic heart disease and degenerative mitral valve diseases. Mitral regurgitation accounts for majority of mitral valve diseases primarily attributed to valve prolapse or flail leaflets causing backflow of blood into the left atrium. North America currently dominates the market due to growing geriatric population susceptible to degenerative mitral valve diseases. Asia Pacific is expected to offer lucrative opportunities, owing to increasing healthcare expenditure and patient awareness.

Transcatheter mitral valve repair using clips, bands or replacement valves has emerged as a minimally invasive alternative to surgical valve repair and replacement. Widespread adoption of these transcatheter mitral procedures is likely to stimulate market growth. However, high cost of these mitral valve devices remains a major barrier particularly in developing regions. Reimbursement uncertainties and lack of clinical evidence for long-term outcomes of new mitral therapies may also impede market revenues.